Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Rectal Cancer”

1,636 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,636 results

Testing effectiveness (Phase 2)Study completedNCT00080951
What this trial is testing

Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology 14
Testing effectiveness (Phase 2)Looking for participantsNCT04165772
What this trial is testing

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

Who this might be right for
Rectal AdenocarcinomaClinical Stage: Stage II (T3-4, N-)Stage III (Any T, N+)+2 more
Memorial Sloan Kettering Cancer Center 200
Testing effectiveness (Phase 2)Ended earlyNCT05678257
What this trial is testing

NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal NeoplasmsColorectal Adenocarcinoma+2 more
NuCana plc 180
Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Testing effectiveness (Phase 2)UnknownNCT05201612
What this trial is testing

Pembrolizumab and Olaparib in Homologous-recombination Deficient (HRD) Advanced Colorectal Cancer (CRC).

Who this might be right for
Metastatic Colorectal Cancer
Grupo Espanol Multidisciplinario del Cancer Digestivo 40
Testing effectiveness (Phase 2)UnknownNCT05451719
What this trial is testing

Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy

Who this might be right for
Colorectal CancerColorectal Cancer Stage IV
Fudan University 116
Testing effectiveness (Phase 2)Study completedNCT00569699
What this trial is testing

Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)

Who this might be right for
Colorectal Cancer
Taiho Pharmaceutical Co., Ltd. 56
Testing effectiveness (Phase 2)Study completedNCT00606398
What this trial is testing

Combined Resection of Colorectal Metastases

Who this might be right for
Colorectal Cancer
University Health Network, Toronto 56
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT01159171
What this trial is testing

Avastin (Bevacizumab) and Oxaliplatin Plus Xeloda (Capecitabine) in Patients With Advanced Colorectal Cancer.

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 50
Testing effectiveness (Phase 2)Study completedNCT04072198
What this trial is testing

Nivolumab Plus FOLFOXIRI/Bevacizumab in First Line Chemotherapy of Advanced Colorectal Cancer RASm/BRAFm Patients

Who this might be right for
Colorectal Cancer
Gruppo Oncologico Italiano di Ricerca Clinica 73
Testing effectiveness (Phase 2)Active Not RecruitingNCT05185947
What this trial is testing

Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer

Who this might be right for
Gynecologic CancerGynecologic NeoplasmsPeritoneal Carcinomatosis+7 more
National Cancer Institute (NCI) 19
Not applicableLooking for participantsNCT06565052
What this trial is testing

The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial

Who this might be right for
Rectal CancerColorectal CancerRectal Cancer Stage II+1 more
Dana-Farber Cancer Institute 40
Early research (Phase 1)Study completedNCT00005616
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT01399684
What this trial is testing

A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Genentech, Inc. 127
Testing effectiveness (Phase 2)Study completedNCT00022698
What this trial is testing

Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 67
Testing effectiveness (Phase 2)Looking for participantsNCT06856187
What this trial is testing

Second-line Standard Treatment Sequential TAS-102 and Bevacizumab Combined With Local Treatment in Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Fudan University 119
Large-scale testing (Phase 3)Study completedNCT00002575
What this trial is testing

Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology 810
Testing effectiveness (Phase 2)Looking for participantsNCT07407465
What this trial is testing

Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.

Who this might be right for
Colorectal CancerColorectal AdenocarcinomaRectal Adenocarcinoma+4 more
Gruppo Oncologico del Nord-Ovest 42
Testing effectiveness (Phase 2)WithdrawnNCT06690281
What this trial is testing

A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies

Who this might be right for
Gastrointestinal CarcinomaPancreatic CancerHepatocellular Cancer+5 more
National Cancer Institute (NCI)
Load More Results